Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 85 /hr

★★★★★

☆☆☆☆☆

Hire Dr. George X.

United Kingdom

USD 85 /hr

Medical & scientific writer with considerable med comms agency and freelance experience following 15+ years in academic research.

Profile Summary

Medical Writer with more than two years experience in a medical communications agency environment and more than 5 years as a freelancer. Having gained a PhD in Molecular Oncology and worked more than 12 years as a postdoctoral research fellow in cancer research and pharmacogenetics, I have extensive experience with academic research writing, editing and proofreading. I provide writing, editing and academic research support in the area of oncology/cancer reserach. I also offer consultancy in project design, proposal, grant and thesis writing as well as supporting services for long distance learning (online / elearning).

Subject Matter Expertise

• ★ Medical Writing
• ☆ Molecular Biology
• ☆ Genetics
• ☆ Oncology
• ☆ Hematology
• ☆ Continuing Medical Education (CME)
• ☆ Cancer Research
• ☆ Scientific Proofreading & Editing
• ☆ Proofreading & Editing

Services

• Writing
• Research

Writing Clinical Trial Documentation, Technical Writing

Research Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Work Experience

Freelance Medical Writer

OncoMed Communications & Consultancy Ltd

June 2015 - Present

Senior Medical Writer

Cancer Communications & Consultancy Ltd

February 2013 - May 2015

Medical Writer & Editor

Freelance

June 2012 - January 2013

Research Fellow

University of Liverpool

September 2003 - May 2012

Visiting Senior Fellow

University of Texas Southwestern Medical Center

June 2004 - November 2005

Temporary Non-Clinical Lecturer

University of Sheffield

May 2001 - August 2003

Research Associate

University of Sheffield

November 1999 - April 2001

Final Year Project Student

University of Surrey

September 1994 - May 1995

Research Assistant

National Hellenic Research Foundation

June 1993 - September 1994

Education

PhD

University of Liverpool

November 1996 - October 1999

PhD in Molecular Oncology

University of Liverpool

November 1996 - September 1999

MSc in Medical Genetics with Immunology

Brunel University

August 1995 - August 1996

BSc(Hons)

University of Surrey

October 1991 - July 1995

BSc(Hons) in Medical Microbiology

University of Surrey

September 1991 - June 1995

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

George Xinarianos, Ana Alfirevic, Jill Durocher, Anisa Elati, Wilfrido León, David Dickens, Steffen Rädisch, Helen Box, Marco Siccardi, Paul Curley, et al.(2015). Misoprostol-induced fever and genetic polymorphisms in drug transporters {SLCO}1B1 and {ABCC}4 in women of Latin American and European ancestry . Pharmacogenomics. p. 1--10. Future Medicine Ltd

U. Oleksiewicz, T. Liloglou, K.-M. Tasopoulou, N. Daskoulidou, J. Bryan, J. R. Gosney, J. K. Field, G. Xinarianos(2013). Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines . Human Molecular Genetics. 22. (16). p. 3207--3217. Oxford University Press ({OUP})

George Xinarianos, José Moltó, Cristina Miranda, Sudeep Pushpakom, Samandhy Cedeño, Bonaventura Clotet, Andrew Owen, Marta Valle(2013). Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in {HIV}-Infected Patients . Clin Pharmacokinet. 52. (7). p. 543--553. Springer Science $\mathplus$ Business Media

A. Giannoudis, L. Wang, A. L. Jorgensen, G. Xinarianos, A. Davies, S. Pushpakom, T. Liloglou, J.-E. Zhang, G. Austin, T. L. Holyoake, et al.(2012). The {hOCT}1 {SNPs} M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia . Blood. 121. (4). p. 628--637. American Society of Hematology

George Xinarianos, Urszula Oleksiewicz, Triantafillos Liloglou, John K. Field(2011). Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family . Cellular and Molecular Life Sciences. 68. (23). p. 3869--3883. Springer Science $\mathplus$ Business Media

George Xinarianos, Alexandros Daskalos, Stella Logotheti, Soultana Markopoulou, John R. Gosney, Anastasia N. Kastania, Vassilis Zoumpourlis, John K. Field, Triantafillos Liloglou(2011). Global {DNA} hypomethylation-induced $\{upDelta}$Np73 transcriptional activation in non-small cell lung cancer . Cancer Letters. 300. (1). p. 79--86. Elsevier {BV}

George Xinarianos, Urszula Oleksiewicz, Nikoleta Daskoulidou, Triantafillos Liloglou, Kelly Tasopoulou, Julie Bryan, John R. Gosney, John K. Field(2011). Neuroglobin and myoglobin in non-small cell lung cancer: Expression, regulation and prognosis . Lung Cancer. 74. (3). p. 411--418. Elsevier {BV}

George Xinarianos, Alexandros Daskalos, Urszula Oleksiewicz, Anastasia Filia, George Nikolaidis, John R. Gosney, Angeliki Malliri, John K. Field, Triantafillos Liloglou(2010). {UHRF}1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer . Cancer. 117. (5). p. 1027--1037. Wiley-Blackwell

George Xinarianos, Suliman Al Omar, Derek Middleton, Ernie Marshall, Dawn Porter, Olaide Raji, John K. Field, Stephen E. Christmas(2010). Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors . Human Immunology. 71. (10). p. 976--981. Elsevier {BV}

E. H. Lips, V. Gaborieau, J. D. McKay, A. Chabrier, R. J. Hung, P. Boffetta, M. Hashibe, D. Zaridze, N. Szeszenia-Dabrowska, J. Lissowska, et al.(2009). Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals . International Journal of Epidemiology. 39. (2). p. 563--577. Oxford University Press ({OUP})

George Xinarianos, Alexandros Daskalos, Georgios Nikolaidis, Paraskevi Savvari, Adrian Cassidy, Roubini Zakopoulou, Athanasios Kotsinas, Vassilis Gorgoulis, John K. Field, Triantafillos Liloglou(2009). Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer . International Journal of Cancer. 124. (1). p. 81--87. Wiley-Blackwell

George Xinarianos, David A. Cairns, Jennifer H. Barrett, Lucinda J. Billingham, Anthea J. Stanley, John K. Field, Phillip J. Johnson, Peter J. Selby, Rosamonde E. Banks(2009). Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison . {PROTEOMICS}. 9. (1). p. 74--86. Wiley-Blackwell

George Xinarianos, James D McKay, Rayjean J Hung, Valerie Gaborieau, Paolo Boffetta, Amelie Chabrier, Graham Byrnes, David Zaridze, Anush Mukeria, Neonilia Szeszenia-Dabrowska, et al.(2008). Lung cancer susceptibility locus at 5p15.33 . Nat Genet. 40. (12). p. 1404--1406. Nature Publishing Group

N. Shivapurkar, V. Stastny, N. Okumura, L. Girard, Y. Xie, C. Prinsen, F. B. Thunnissen, I. I. Wistuba, B. Czerniak, E. Frenkel, et al.(2008). Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene . Cancer Research. 68. (18). p. 7448--7456. American Association for Cancer Research ({AACR})

George Xinarianos, Rayjean J. Hung, James D. McKay, Valerie Gaborieau, Paolo Boffetta, Mia Hashibe, David Zaridze, Anush Mukeria, Neonilia Szeszenia-Dabrowska, Jolanta Lissowska, et al.(2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 . Nature. 452. (7187). p. 633--637. Nature Publishing Group

George Xinarianos, John K. Field, Adrian Cassidy, Jonathan Miles, Triantafillos Liloglou, Dawn Smith, Asaf Niaz, Richard Page, Stephen Duffy(2007). Biomarkers and risk models for stratification of high risk individuals . Journal of Thoracic Oncology. 2. (Supplement 4). p. S176. Ovid Technologies (Wolters Kluwer Health)

M. Ehrich, J. K. Field, T. Liloglou, G. Xinarianos, P. Oeth, M. R. Nelson, C. R. Cantor, D. van den Boom(2006). Cytosine Methylation Profiles as a Molecular Marker in Non-Small Cell Lung Cancer . Cancer Research. 66. (22). p. 10911--10918. American Association for Cancer Research ({AACR})

G. Xinarianos(2006). Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer . Human Molecular Genetics. 15. (13). p. 2038--2044. Oxford University Press ({OUP})

M. Ehrich, M. R. Nelson, P. Stanssens, M. Zabeau, T. Liloglou, G. Xinarianos, C. R. Cantor, J. K. Field, D. van den Boom(2005). Quantitative high-throughput analysis of {DNA} methylation patterns by base-specific cleavage and mass spectrometry . Proceedings of the National Academy of Sciences. 102. (44). p. 15785--15790. Proceedings of the National Academy of Sciences

T. Liloglou, F. McRonald, G. Xinarianos, N. Bowers, J. Risk, J. Field(2005). P-078 Abnormal {CYGB} expression and hypermethylation in non-small cell lung cancer . Lung Cancer. 49. p. S134. Elsevier {BV}

J. Field, G. Xinarianos, J. Myles, G. Nikolaidis, A. Cassidy, S. Duffy, L. Liloglou(2005). {PD}-053 Lung cancer susceptibility: A {CDKN}1A promoter polymorphismenhances the risk for lung cancer . Lung Cancer. 49. p. S81--S82. Elsevier {BV}

George Xinarianos, James W. F. Catto, Julian L. Burton, Mark Meuth, Freddie C. Hamdy(2003). Differential expression of {hMLH}1 and {hMSH}2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability . International Journal of Cancer. 105. (4). p. 484--490. Wiley-Blackwell

S Miyakis, T Liloglou, S Kearney, G Xinarianos, D.A Spandidos, J.K Field(2003). Absence of mutations in the {VHL} gene but frequent loss of heterozygosity at 3p25{\textendash}26 in non-small cell lung carcinomas . Lung Cancer. 39. (3). p. 273--277. Elsevier {BV}

George Xinarianos, Triantafillos Liloglou, Wendy Prime, George Sourvinos, Andreas Karachristos, John R. Gosney, Demetrios A. Spandidos, John K. Field(2002). p53 status correlates with the differential expression of the {DNA} mismatch repair protein {MSH}2 in non-small cell lung carcinoma . International Journal of Cancer. 101. (3). p. 248--252. Wiley-Blackwell

George Xinarianos, James Catto, Julian Burton, Mark Meuth, Freddie Hamdy(2002). Differential expression of mismatch repair proteins, {MLH}1 and {MSH}2, in Transitional Cell Carcinoma ({TCC}) of the bladder . European Urology Supplements. 1. (1). p. 22. Elsevier {BV}

T. Carrol, V. Hakin-Smith, M. Teo, D. Levy, D. Jellinek, M. Meuth, J.A. Royds, G. Xinarianos(2001). Telomere length as a prognostic marker in glioblastomas . European Journal of Cancer. 37. p. S23. Elsevier {BV}

G Xinarianos, F.M Scott, T Liloglou, W Prime, L Turnbull, M Walshaw, J.K Field(2000). Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease . Lung Cancer. 28. (1). p. 37--42. Elsevier {BV}

T Liloglou, P Maloney, G Xinarianos, S Fear, J K Field(2000). Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors . International Journal of Oncology. Spandidos Publications

G Xinarianos, F M Scott, T Liloglou, W Prime, J Callaghan, J R Gosney, J K Field(1999). Telomerase activity in non-small cell lung carcinomas correlates with smoking status . International Journal of Oncology. Spandidos Publications

J.K. Field, T. Liloglou, G. Xinarianos, L. Turnbull, M. Walshaw(1999). Genomic instability in bronchial lavage specimens from individuals with no evidence of lung cancer: an early detection marker? . European Journal of Cancer. 35. p. S104. Elsevier {BV}

George Xinarianos, John K. Field, Judith Youngson, Helen L. Ross, Lakis Liloglou, Frank Scott, Wendy Prime, Martin Walshaw, John R. Gosney, Lesley Turnbull, et al.(1997). Molecular-pathological assessment of individuals with a high risk of developing lung cancer . Lung Cancer. 18. p. 39. Elsevier {BV}

M ERGAZAKI, G XINARIANOS, A GIANNOUDIS, N MARKOMICHELAKIS, J TSAMPARLAKIS, DA SPANDIDOS(1994). {DETECTION} {OF} {HSV}, {CMV} {AND} {EBV} {BY} {THE} {POLYMERASE} {CHAIN}-{REACTION} {TECHNIQUE} {IN} {PATIENTS} {WITH} {INFLAMMATORY} {EYE}-{DISEASES} . Oncol Rep. Spandidos Publications

DA SPANDIDOS, G XINARIANOS, M ERGAZAKI, A GIANNOUDIS, J TSAMPARLAKIS(1994). {THE} {PRESENCE} {OF} {HERPESVIRUSES} {IN} {PTERYGIUM} . International Journal of Oncology. Spandidos Publications

M ERGAZAKI, G XINARIANOS, A GIANNOUDIS, M KOFFA, T LILOGLOU, C KATTAMIS, DA SPANDIDOS(1994). {DETECTION} {OF} {HUMAN} {CYTOMEGALOVIRUS} {AND} {EPSTEIN}-{BARR}-{VIRUS} {BY} {THE} {POLYMERASE} {CHAIN}-{REACTION} {IN} {PATIENTS} {WITH} {BETA}-{THALASSEMIA} . Oncol Rep. Spandidos Publications

M ERGAZAKI, G XINARIANOS, M KOFFA, T LILOGLOU, DA SPANDIDOS(1994). {DETECTION} {OF} {HUMAN} {CYTOMEGALOVIRUS} {BY} {THE} {POLYMERASE} {CHAIN}-{REACTION} {IN} {IMMUNOSUPPRESSED} {AND} {IMMUNOCOMPROMISED} {PATIENTS} . Oncol Rep. Spandidos Publications